Seriously



















Biggest biologics launch failure for the entire industry in 2018?

I was thinking... no, Raptiva was a mess. Then I remembered it was a clinical snafu. Genentech bailed because the drug had issues. If Sun had that drug they would still be trying to bs docs into writing it. No when to fold em brah.
 












The only think working for them is TARO. Cash cow but low share price. They are going to buy it out and use Taro profits to save themselves from another embarrassing year.